These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6340575)

  • 21. Crossover comparison of cibenzoline and quinidine in ambulatory patients with chronic ventricular arrhythmias.
    Mohiuddin SM; Woodruff MP; Esterbrooks DJ; Mooss AN; Hansen JM; Hilleman DE
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):525-9. PubMed ID: 2470988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind placebo-controlled evaluation of propafenone in suppressing ventricular ectopic activity.
    Hodges M; Salerno D; Granrud G
    Am J Cardiol; 1984 Nov; 54(9):45D-50D. PubMed ID: 6388303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indecainide for treatment of ventricular ectopic depolarizations: efficacy, pharmacokinetics, hemodynamic effects and safety.
    Salerno DM; Krejci J; Granrud G; Hodges M
    J Am Coll Cardiol; 1988 Apr; 11(4):843-50. PubMed ID: 3351153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerance of intravenous flecainide in patients with chronic high frequency ventricular arrhythmias.
    Stroobandt R; Andries E; van Mieghem W; Kesteloot H
    Eur Heart J; 1984 Nov; 5(11):876-82. PubMed ID: 6397356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indecainide compared with quinidine for chronic stable ventricular arrhythmias secondary to coronary artery disease or to cardiomyopathy.
    Giardina EG; Zaim S; Saroff AL; Kirschenbaum M
    Am J Cardiol; 1987 Sep; 60(7):584-9. PubMed ID: 2442993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Holmes B; Heel RC
    Drugs; 1985 Jan; 29(1):1-33. PubMed ID: 3882390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
    Bluschke V; Breithardt G; Abendroth RR; Seipel L
    Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cibenzoline for high-frequency ventricular arrhythmias: a short-term comparison with quinidine and a long-term follow-up.
    Palakurthy PR; Maldonado C; Sohi G; Flowers NC
    J Clin Pharmacol; 1987 Apr; 27(4):283-7. PubMed ID: 3680585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias.
    Morganroth J; Oshrain C; Steele PP
    Am J Cardiol; 1985 Oct; 56(10):581-5. PubMed ID: 3931448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of lorcainide and quinidine in the treatment of ventricular ectopy.
    Vlay SC; Mallis GI; Singh S; Cohn PF
    Chest; 1984 Jul; 86(1):80-3. PubMed ID: 6734299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of flecainide acetate in the treatment of premature ventricular contractions.
    Abitbol H; Califano JE; Abate C; Beilis P; Castellanos H
    Am Heart J; 1983 Feb; 105(2):227-30. PubMed ID: 6823803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.
    Duff HJ; Roden DM; Maffucci RJ; Vesper BS; Conard GJ; Higgins SB; Oates JA; Smith RF; Woosley RL
    Am J Cardiol; 1981 Dec; 48(6):1133-40. PubMed ID: 7304461
    [No Abstract]   [Full Text] [Related]  

  • 33. Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. A meta-analysis.
    Morganroth J; Goin JE
    Circulation; 1991 Nov; 84(5):1977-83. PubMed ID: 1834365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A proposal for the clinical use of flecainide.
    Anderson JL; Stewart JR; Crevey BJ
    Am J Cardiol; 1984 Feb; 53(5):112B-119B. PubMed ID: 6364767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flecainide: a new class Ic antidysrhythmic.
    Smith GH
    Drug Intell Clin Pharm; 1985 Oct; 19(10):703-7. PubMed ID: 3902429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram.
    Morganroth J; Horowitz LN
    Am J Cardiol; 1984 Feb; 53(5):89B-94B. PubMed ID: 6695821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy of oral pirmenol in suppressing ventricular premature depolarizations.
    de Buitleir M; Crevey BJ; Johnson T; Kou WH; Nelson SD; Schmaltz S; Morady F
    Am Heart J; 1988 Aug; 116(2 Pt 1):379-84. PubMed ID: 2456681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, safety, hemodynamic effects, and pharmacokinetics of high-dose moricizine during short- and long-term therapy.
    Salerno DM; Sharkey PJ; Granrud GA; Asinger RW; Hodges M
    Clin Pharmacol Ther; 1987 Aug; 42(2):201-9. PubMed ID: 3301153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short- and long-term therapeutic efficacy of quinidine sulfate for the treatment of chronic ventricular arrhythmias.
    Panidis I; Morganroth J
    J Clin Pharmacol; 1982; 22(8-9):379-84. PubMed ID: 6752212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term antiarrhythmic therapy with flecainide.
    Meinertz T; Zehender MK; Geibel A; Treese N; Hofmann T; Kasper W; Pop T
    Am J Cardiol; 1984 Jul; 54(1):91-6. PubMed ID: 6741844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.